Boost your NAD+ with NMN & Resveratrol
Repair damaged DNA
NMN-administered mice showed higher food intake but lower body weight compared to control mice during the process of aging. This was achieved because NMN enhanced their energy metabolism.
A clinical trial using resveratrol increased energy metabolism in obese humans.
Resveratrol induces autophagy independent of SIRT1 by inhibiting mTOR activity, a key regulator of autophagy.
30 days of resveratrol supplementation in obese humans resulted in improved mitochondrial metabolism through the AMPK-SIRT1-PGC-1α axis.
Dietary administration of NMN in a long-term rodent study improved mitochondrial function.
Mice with Alzheimer’s disease were given NMN every other day for 28 days and showed improved brain mitochondria respiratory capacity.
Healthy adults aged 50-75 years, who took resveratrol every day for 26 weeks improved their ability to complete memory tasks.
Resveratrol has shown to reduce neuronal inflammation and improve cognitive performance by mitigating hallmarks of Alzheimer’s.
NMN Restores Brain Function by Improving Neurovascular Coupling NMN shows to have cerebral microvascular protective effects in aged mice and findings pose the question of NMN as a potential therapy to prevent aged-induced vascular cognitive impairment
When people who had a heart attack took resveratrol daily for 3 months, they significantly decreased their LDLc and improved both left ventricle diastolic function and endothelial function
NMN given to mice reversed mitochondrial protein hyperacetylation and delayed development of heart failure.
Resveratrol tricks the body into thinking it’s fasting by activating the same pathways that are turned on when one is fasted. A clinical trial using resveratrol promoted caloric restriction-like effects by improving circulating glucose, insulin, and triglyceride concentrations compared to placebo
A collection and analysis of studies on Resveratrol and other polyphenols that demonstrate powerful anti-viral properties, and how they may be useful for combating COVID-19.
Resveratrol strongly inhibited the replication of influenza virus in MDCK cells, and significantly improved survival and decreased pulmonary viral titers in influenza virus-infected mice.
Resveratrol and pterostilbene exhibit potent antiviral properties against SARS-CoV-2 in vitro.